Literature DB >> 23080410

Inter-cellular signaling network reveals a mechanistic transition in tumor microenvironment.

Yu Wu1, Lana X Garmire, Rong Fan.   

Abstract

We conducted inter-cellular cytokine correlation and network analysis based upon a stochastic population dynamics model that comprises five cell types and fifteen signaling molecules inter-connected through a large number of cell-cell communication pathways. We observed that the signaling molecules are tightly correlated even at very early stages (e.g. the first month) of human glioma, but such correlation rapidly diminishes when tumor grows to a size that can be clinically detected. Further analysis suggests that paracrine is shown to be the dominant force during tumor initiation and priming, while autocrine supersedes it and supports a robust tumor expansion. In correspondence, the cytokine correlation network evolves through an increasing to decreasing complexity. This study indicates a possible mechanistic transition from the microenvironment-controlled, paracrine-based regulatory mechanism to self-sustained rapid progression to fetal malignancy. It also reveals key nodes that are responsible for such transition and can be potentially harnessed for the design of new anti-cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23080410      PMCID: PMC3502715          DOI: 10.1039/c2ib20044a

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  51 in total

1.  Cancer. Awakening immunity.

Authors:  Hans Schreiber; Donald A Rowley
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

2.  Accumulation of driver and passenger mutations during tumor progression.

Authors:  Ivana Bozic; Tibor Antal; Hisashi Ohtsuki; Hannah Carter; Dewey Kim; Sining Chen; Rachel Karchin; Kenneth W Kinzler; Bert Vogelstein; Martin A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

3.  Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis.

Authors:  S Ghosh; S Elankumaran; I K Puri
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

4.  Individual histories and selection in heterogeneous populations.

Authors:  Stanislas Leibler; Edo Kussell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-02       Impact factor: 11.205

Review 5.  In silico models of cancer.

Authors:  Lucas B Edelman; James A Eddy; Nathan D Price
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

6.  Probing the invasiveness of prostate cancer cells in a 3D microfabricated landscape.

Authors:  Liyu Liu; Bo Sun; Jonas N Pedersen; Koh-Meng Aw Yong; Robert H Getzenberg; Howard A Stone; Robert H Austin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-07       Impact factor: 11.205

Review 7.  The perivascular niche microenvironment in brain tumor progression.

Authors:  Nikki Charles; Eric C Holland
Journal:  Cell Cycle       Date:  2010-08-01       Impact factor: 4.534

8.  Interaction of tumor with its micro-environment: A mathematical model.

Authors:  Yangjin Kim; Avner Friedman
Journal:  Bull Math Biol       Date:  2009-11-12       Impact factor: 1.758

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Evolutionary dynamics of intratumor heterogeneity.

Authors:  Yoh Iwasa; Franziska Michor
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

View more
  8 in total

1.  Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.

Authors:  Judith Schwartzbaum; Michal Seweryn; Christopher Holloman; Randall Harris; Samuel K Handelman; Grzegorz A Rempala; Ruo-Pan Huang; Brett Burkholder; Adam Brandemihl; Henrik Kallberg; Tom Borge Johannesen; Anders Ahlbom; Maria Feychting; Tom K Grimsrud
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

2.  Metazoans evolved by taking domains from soluble proteins to expand intercellular communication network.

Authors:  Hyun-Jun Nam; Inhae Kim; James U Bowie; Sanguk Kim
Journal:  Sci Rep       Date:  2015-04-29       Impact factor: 4.379

3.  A nested case-control study of 277 prediagnostic serum cytokines and glioma.

Authors:  Judith Schwartzbaum; Min Wang; Elisabeth Root; Maciej Pietrzak; Grzegorz A Rempala; Ruo-Pan Huang; Tom Borge Johannesen; Tom K Grimsrud
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

4.  Single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell-cell interaction.

Authors:  Minsuk Kwak; Luye Mu; Yao Lu; Jonathan J Chen; Kara Brower; Rong Fan
Journal:  Front Oncol       Date:  2013-02-06       Impact factor: 6.244

5.  Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk.

Authors:  Keon-Young Park; Gande Li; Manu O Platt
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

6.  Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner.

Authors:  Heyang Xu; Wei Lai; Yang Zhang; Lu Liu; Xingxi Luo; Yujie Zeng; Heng Wu; Qiusheng Lan; Zhonghua Chu
Journal:  BMC Cancer       Date:  2014-05-10       Impact factor: 4.430

Review 7.  Epigenetic changes in fibroblasts drive cancer metabolism and differentiation.

Authors:  Rajeev Mishra; Subhash Haldar; Surabhi Suchanti; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2019-12       Impact factor: 5.678

8.  The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation.

Authors:  Sharon Bajda; Arturo Blazquez-Navarro; Björn Samans; Patrizia Wehler; Sviatlana Kaliszczyk; Leila Amini; Michael Schmueck-Henneresse; Oliver Witzke; Ulf Dittmer; Timm H Westhoff; Richard Viebahn; Petra Reinke; Oliver Thomusch; Christian Hugo; Sven Olek; Toralf Roch; Nina Babel
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.